Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Public ClinicalTrials.gov record NCT00613002. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of the Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women
Study identification
- NCT ID
- NCT00613002
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- BioSante Pharmaceuticals
- Industry
- Enrollment
- 597 participants
Conditions and interventions
Conditions
Interventions
- testosterone gel Drug
- placebo gel Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Aug 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Jan 9, 2013
2006 – 2011
United States locations
- U.S. sites
- 60
- U.S. states
- 30
- U.S. cities
- 59
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| BioSante Site #215 | Birmingham | Alabama | 35209 | — |
| BioSante Site #095 | Hoover | Alabama | 35216 | — |
| BioSante Site #014 | Huntsville | Alabama | 35801 | — |
| BioSante Site #027 | Glendale | Arizona | 85308 | — |
| BioSante Site #040 | Tucson | Arizona | 85715 | — |
| BioSante Site #052 | Hot Springs | Arkansas | 71913 | — |
| BioSante Site #182 | Buena Park | California | 90620 | — |
| BioSante Site #008 | San Diego | California | 92108 | — |
| BioSante Site #007 | Denver | Colorado | 80218 | — |
| BioSante Site #216 | Denver | Colorado | 80239 | — |
| BioSante Site #036 | Ridgefield | Connecticut | 06877 | — |
| BioSante Site #013 | Washington D.C. | District of Columbia | 20036 | — |
| BioSante Site #024 | Miami | Florida | 33126 | — |
| BioSante Site #219 | Pinellas Park | Florida | 33781 | — |
| BioSante Site #041 | St. Petersburg | Florida | 33709 | — |
| BioSante Site #009 | West Palm Beach | Florida | 33409 | — |
| BioSante Site #189 | Addison | Illinois | 60101 | — |
| BioSante Site #005 | Shreveport | Louisiana | 71115 | — |
| BioSante Site #004 | Baltimore | Maryland | 21285 | — |
| BioSante Site #044 | Detroit | Michigan | 48201 | — |
| BioSante Site #047 | Grand Rapids | Michigan | 49503 | — |
| BioSante Site #033 | Saginaw | Michigan | 48604 | — |
| BioSante Site #031 | Saint Clair Shores | Michigan | 48081 | — |
| BioSante Site #208 | Edina | Minnesota | 55435 | — |
| BioSante Site #198 | Saint Paul | Minnesota | 55108 | — |
| BioSante Site #051 | Missoula | Montana | 59808 | — |
| BioSante Site #006 | Lincoln | Nebraska | 68501 | — |
| BioSante Site #217 | Las Vegas | Nevada | 89146 | — |
| BioSante Site #015 | Poughkeepsie | New York | 12601 | — |
| BioSante Site #059 | Cary | North Carolina | 27518 | — |
| BioSante Site #079 | Charlotte | North Carolina | 28209 | — |
| BioSante Site #061 | Winston-Salem | North Carolina | 27103 | — |
| BioSante Site #056 | Fargo | North Dakota | 58103 | — |
| BioSante Site #210 | Akron | Ohio | 44311 | — |
| BioSante Site #212 | Cincinnati | Ohio | 45249 | — |
| BioSante Site #213 | Columbus | Ohio | 43212 | — |
| BioSante Site #050 | Eugene | Oregon | 97401 | — |
| BioSante Site #197 | Wexford | Pennsylvania | 15090 | — |
| BioSante Site #089 | Columbia | South Carolina | 29201 | — |
| BioSante Site #209 | Greer | South Carolina | 29651 | — |
| BioSante Site #097 | Hilton Head Island | South Carolina | 29926 | — |
| BioSante Site #038 | Mt. Pleasant | South Carolina | 29464 | — |
| BioSante Site #049 | Watertown | South Dakota | 57201 | — |
| BioSante Site #093 | Bristol | Tennessee | 37620 | — |
| BioSante Site #069 | Chattanooga | Tennessee | 37404 | — |
| BioSante Site #078 | Memphis | Tennessee | 38120 | — |
| BioSante Site #042 | Nashville | Tennessee | 37203 | — |
| BioSante Site #048 | Austin | Texas | 78705 | — |
| BioSante Site #073 | Corpus Christi | Texas | 78414 | — |
| BioSane Site #220 | Dallas | Texas | 75231 | — |
| BioSante Site #039 | Houston | Texas | 77054 | — |
| BioSante Site #211 | San Antonio | Texas | 78229 | — |
| BioSante Site #218 | Murray | Utah | 84123 | — |
| BioSante Site #096 | Williston | Vermont | 05495 | — |
| BioSante Site #003 | Charlottesville | Virginia | 22903 | — |
| BioSante Site #086 | Norfolk | Virginia | 23502 | — |
| BioSante Site #053 | Richmond | Virginia | 23294 | — |
| BioSante Site #090 | Virginia Beach | Virginia | 23456 | — |
| BioSante Site #083 | Mountlake Terrace | Washington | 98043 | — |
| BioSante Site #181 | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00613002, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00613002 live on ClinicalTrials.gov.